<DOC>
	<DOC>NCT00832377</DOC>
	<brief_summary>A study to evaluate the effect of the 12-week treatment with timolol/dorzolamide combination eyedrops (COSOPT) on decrease in intraocular pressure (IOP) at 2 hours after the study drug administration</brief_summary>
	<brief_title>COSOPT (Timolol/Dorzolamide Combination) Normal Tension Glaucoma Study (MK0507A-161)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Low Tension Glaucoma</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<criteria>Patients who have not been treated with a glaucoma medication within 6 weeks prior to study participation after diagnosis with primary openangle glaucoma Patients with primary openangle glaucoma based on gonioscopy Patients with normal tension glaucoma diagnosed based on accompanying optic disc cupping and reappearance of visual field defect corresponding to retinal nerve fiber layer defect. Subjects with &lt; 22 mm Hg of diurnal IOP measured using Goldmann applanation tonometer (every two hours between 9 a.m. and 5 p.m.) Patients with another type of glaucoma but primary openangle glaucoma Patients treated with other glaucoma medications within 6 weeks prior to study participation Patients with a history of chronic ocular inflammation or recurrent ocular inflammation Patients using contact lenses Patients who are allergic to timolol or dorzolamide Patients with a history of any of the following COSOPT (timolol/dorzolamide combination) contraindications: Reactive airway diseases Sinus bradycardia, second or third degree atrioventricular block, overt cardiac failure, cardiogenic shock Severe renal impairment Patients with a history of significant ocular trauma or intraocular surgery within 6 months before participating the study, or intraocular laser surgery within 3 months before the participating the study Patients with a history of a corneal disease Patients who are using steroid or used the drug for more than 2 weeks within 12 months before participating the study Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>